ANG Lifesciences India informs about updates

13 Sep 2021 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ANG Lifesciences India has informed that the company has already crossed 200 cr revenue milestone and going forward, the company is expecting similar robust growth in coming quarters. The Company is expected to post turnover around Rs 400-450 cr. with expected IT in measurable terms Rs 15 cr approx in F.Y. 2021-22. Also, the Company has been able to show handsome growth backed by persistent and focused efforts by the management in its goal of maintaining the growth trend on going forward.

The above information is a part of company’s filings submitted to BSE.

ANG Lifesciences Share Price

28.28 -0.53 (-1.84%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×